Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Cambrex Corporation

NYSE: CBMHealthcare / Biotechnology / USA
44.43-0.84-1.86%Vol 53 5221Y Perf -10.35%
Dec 10th, 2018 11:49
BID44.27 ASK44.39
Open45.28 Previous Close45.27
Pre-Market- After-Trading45.27
 - -%  - -%
Target Price
60.75 
Analyst Rating
Strong Buy 1.40
Potencial %
37.51 
Finscreener Ranking
★★★★★     64.71
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★★★     69.25
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     69.70
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 491 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.85 
Earnings Date
8th Nov 2018

Today's Price Range

43.9645.43

52wk Range

43.9669.43

5 Year PE Ratio Range

5.3033.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-10.89%
3 Months
-32.38%
6 Months
-0.94%
1 Year
-10.35%
3 Years
-12.57%
5 Years
139.52%

Quotes

Name / TickerPriceChg.Chg.%
CBM44.43-0.8400-1.86
AAPL165.25-3.2400-1.92
GOOG1 036.690.11000.01
MSFT104.970.15000.14
XOM75.26-2.3800-3.07
WFC48.62-1.6400-3.26
JNJ143.15-2.2800-1.57
FB140.583.16002.30
GE6.84-0.1700-2.43
JPM100.05-3.2400-3.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.00
Current Ratio
4.50
Long Term Debt to Total Capital
0.33
Total Debt to Equity
0.49
Interest Coverage
374.70
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
39.10
EBIT Margin
24.80
EBITDA Margin
30.50
Pre-tax Profit Margin
19.90
Profit Margin
23.22
ValuationValueIndustryS&P 500US Markets
PE Ratio
12.20
PB Ratio
2.43
PS Ratios
2.84
Price to Cash Flow
13.80
Price to Free Cash Flow
-4.50
Cash Flow Per Share
3.47
Price to Tangible Book
8.19
Book Value per Share
19.64
Enterprise Value (in ths.)
1 833 040
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
21.19
ROE last 12 Months
22.72
Return on Assets (5Y Avg)
6.67
ROA last 12 Months
13.51
Return on Capital (5Y Avg)
18.37
ROC last 12 Months
14.55
Return on invested Capital Q
2.77
Return on invested Capital Y
21.56
Assets Turnover
0.30
Receivables Turnover
2.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
566 080
Revenue per Share
16.87
Revenue Growth 3 Years
9.08
Revenue Growth 5 Years
12.61
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 20180.590.7933.90
Q02 20180.661.2183.33
Q01 20180.500.7244.00
Q04 20171.101.2715.45
Q03 20170.470.5517.02
Q02 20170.750.761.33
Q01 20170.510.6833.33
Q04 2016-1.18-
Earnings Per EndEstimateRevision %Trend
12/2018 QR1.3210.92Positive
12/2018 QR1.190.00-
12/2018 FY2.77-1.77Negative
12/2019 FY2.97--
Next Report Date-
Estimated EPS Next Report0.59
Estimates Count1
EPS Growth Next 5 Years %10.00
Volume Overview
Volume53 522
Shares Outstanding (in ths.)33 560
Trades Count256
Dollar Volume1 941 397
Avg. Volume359 728
Avg. Weekly Volume313 718
Avg. Monthly Volume420 240
Avg. Quarterly Volume419 252

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

45%55%

Bearish Bullish

49%51%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

There are no comments yet.

News